Luca Giliberto

3.2k total citations · 1 hit paper
44 papers, 2.6k citations indexed

About

Luca Giliberto is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Luca Giliberto has authored 44 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Physiology, 12 papers in Molecular Biology and 11 papers in Neurology. Recurrent topics in Luca Giliberto's work include Alzheimer's disease research and treatments (31 papers), Dementia and Cognitive Impairment Research (7 papers) and Neuroinflammation and Neurodegeneration Mechanisms (7 papers). Luca Giliberto is often cited by papers focused on Alzheimer's disease research and treatments (31 papers), Dementia and Cognitive Impairment Research (7 papers) and Neuroinflammation and Neurodegeneration Mechanisms (7 papers). Luca Giliberto collaborates with scholars based in United States, Italy and United Kingdom. Luca Giliberto's co-authors include Massimo Tabaton, Luciano D'adamio, Roberta Borghi, Elena Tamagno, Michela Guglielmotto, Peter J. Davies, Philippe Marambaud, Mark A. Smith, George Perry and Jessica Lobo and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Luca Giliberto

43 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide Metabolism

2010 534 citations Valérie Vingtdeux, Luca Giliberto et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Luca Giliberto

Since Specialization

Citations

This map shows the geographic impact of Luca Giliberto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Giliberto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Giliberto more than expected).

Fields of papers citing papers by Luca Giliberto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Giliberto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Giliberto. The network helps show where Luca Giliberto may publish in the future.

Co-authorship network of co-authors of Luca Giliberto

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Giliberto. A scholar is included among the top collaborators of Luca Giliberto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Giliberto. Luca Giliberto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Non-Electrophilic Activation of NRF2 in Neurological Disorders: Therapeutic Promise of Non-Pharmacological Strategies 2025 ·Antioxidants ·Chunyan Li, Keren Powell, Luca Giliberto, (unknown), Cristina d’Abramo, Daniel M. Sciubba, (unknown)	1
2	Differential associations of APOE and TREM2 variants with glial fibrillary acidic protein and neurofilament light in plasma of UK Biobank participants support distinct disease mechanisms 2025 ·Molecular Psychiatry ·Yun Freudenberg‐Hua, Luca Giliberto, Cristina d’Abramo, Wentian Li, Yilong Ma, Alison Goate, Jeremy Koppel	1
3	An Open-Label, Pilot Study of Daratumumab SC in Mild to Moderate Alzheimer’s Disease 2024 ·Journal of Alzheimer s Disease Reports ·Marc L. Gordon, Erica Christen, (unknown), Michelle N. Gong, Fung Lam, Luca Giliberto, Jesús J. Gomar, Jeremy Koppel	2
4	Creutzfeldt-Jakob disease presenting as psychiatric disorder: case presentation and systematic review 2024 ·Frontiers in Neurology ·(unknown), (unknown), (unknown), Marc L. Gordon, Ana M. Franceschi, Luca Giliberto	1
5	NRF2/HO-1 pathway limits TLR4- and TLR7/8-dependent IRF5 activation in macrophage-like cells 2023 ·Free Radical Biology and Medicine ·(unknown), Anna Lisa Furfaro, Cristina d’Abramo, Luca Giliberto, Mariapaola Nitti	1
6	Retrospective review COVID-19 vaccine induced thrombotic thrombocytopenia and cerebral venous thrombosis-what can we learn from the immune response 2022 ·Clinical Imaging ·Ana M. Franceschi, (unknown), (unknown), Richard Libman, Luca Giliberto, Sean Clouston, Maurício Castillo, Claudia Kirsch	5
7	Neurovascular Complications in COVID-19 Infection: Case Series 2020 ·American Journal of Neuroradiology ·Ana M. Franceschi, Rohan Arora, Robert Wilson, Luca Giliberto, Richard Libman, Maurício Castillo	20
8	Anti-tau conformational scFv MC1 antibody efficiently reduces pathological tau species in adult JNPL3 mice 2018 ·Acta Neuropathologica Communications ·(unknown), Luca Giliberto, Santiago Ruiz, (unknown), Philippe Marambaud, Cristina d’Abramo	41
9	Abolishing Tau cleavage by caspases at Aspartate421 causes memory/synaptic plasticity deficits and pre-pathological Tau alterations 2017 ·Translational Psychiatry ·Fabrizio Biundo, Cristina d’Abramo, Marc D. Tambini, H Zhang, Dolores Del Prete, (unknown), Luca Giliberto, Ottavio Arancio, Luciano D'adamio	18
10	Aβ1‐42‐mediated down‐regulation of Uch‐L1 is dependent on NF‐κB activation and impaired BACE1 lysosomal degradation 2012 ·Aging Cell ·Michela Guglielmotto, Debora Monteleone, Marina Boido, Antonio Piras, Luca Giliberto, Roberta Borghi, Alessandro Vercelli, Michele Fornaro, Massimo Tabaton, Elena Tamagno	56
11	Amyloid-β ₄₂ Activates the Expression of BACE1 Through the JNK Pathway 2011 ·Journal of Alzheimer s Disease ·Michela Guglielmotto, Debora Monteleone, Luca Giliberto, Michele Fornaro, Roberta Borghi, Elena Tamagno, Massimo Tabaton	50
12	Memory Deficits Due to Familial British DementiaBRI2Mutation Are Caused by Loss ofBRI2Function Rather than Amyloidosis 2010 ·Journal of Neuroscience ·Robert Tamayev, Luca Giliberto, Wei Li, Cristina d’Abramo, Ottavio Arancio, Rubén Vidal, Luciano D'adamio	46
13	AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide Metabolism breakdown → 2010 ·Journal of Biological Chemistry ·Valérie Vingtdeux, Luca Giliberto, Haitian Zhao, Pallavi Chandakkar, Qingli Wu, James E. Simon, Elsa M. Janle, Jessica Lobo, Mário G. Ferruzzi, Peter J. Davies, Philippe Marambaud	534
14	Generation and Initial Characterization of FDD Knock In Mice 2009 ·PLoS ONE ·Luca Giliberto, Shuji Matsuda, Rubén Vidal, Luciano D'adamio	28
15	BRI2 Inhibits Amyloid β-Peptide Precursor Protein Processing by Interfering with the Docking of Secretases to the Substrate 2008 ·Journal of Neuroscience ·Shuji Matsuda, Luca Giliberto, Yukiko Matsuda, Eileen McGowan, Luciano D'adamio	81
16	The up‐regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1α 2008 ·Journal of Neurochemistry ·Michela Guglielmotto, Manuela Aragno, Riccardo Autelli, Luca Giliberto, Erica Novo, Sebastiano Colombatto, Oliviero Danni, Maurizio Parola, Mark A. Smith, George Perry, Elena Tamagno, Massimo Tabaton	205
17	JNK and ERK1/2 pathways have a dual opposite effect on the expression of BACE1 2008 ·Neurobiology of Aging ·Elena Tamagno, Michela Guglielmotto, Luca Giliberto, Antonella Vitali, Roberta Borghi, Riccardo Autelli, Oliviero Danni, Massimo Tabaton	73
18	Oxidative stress activates a positive feedback between the γ‐ and β‐secretase cleavages of the β‐amyloid precursor protein 2007 ·Journal of Neurochemistry ·Elena Tamagno, Michela Guglielmotto, Manuela Aragno, Roberta Borghi, Riccardo Autelli, Luca Giliberto, Giuseppe Muraca, Oliviero Danni, Xiongwei Zhu, Mark A. Smith, George Perry, Dong‐Gyu Jo, Mark P. Mattson, Massimo Tabaton	285
19	β-Amyloid Is Different in Normal Aging and in Alzheimer Disease 2005 ·Journal of Biological Chemistry ·Alessandra Piccini, Claudio Russo, Alessandra Gliozzi, Annalisa Relini, Antonella Vitali, Roberta Borghi, Luca Giliberto, Andrea Armirotti, Cristina D’Arrigo, Angela Bachi, Angela Cattaneo, Claudio Canale, Silvia Torrassa, Takaomi C. Saido, William R. Markesbery, Pierluigi Gambetti, Massimo Tabaton	168
20	CD36 overexpression in human brain correlates with β-amyloid deposition but not with Alzheimer's disease 2004 ·Free Radical Biology and Medicine ·Roberta Ricciarelli, Cristina d’Abramo, Jean‐Marc Zingg, Luca Giliberto, William R. Markesbery, Angelo Azzi, Umberto M. Marinari, Maria Adelaide Pronzato, Massimo Tabaton	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact